Demonstration of Platelet-Derived Microvesicles in Blood from Patients with Activated Coagulation and Fibrinolysis Using a Filtration Technique and Western Blotting

Pål Andrè Holme; Nils Olav Solum; Frank Brosstad; Magnus Røger; Michael Abdelnoor

doi:10.1055/s-0038-1648939

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1994; 72(05): 666-671
DOI: 10.1055/s-0038-1648939

Original Article

Schattauer GmbH Stuttgart

Demonstration of Platelet-Derived Microvesicles in Blood from Patients with Activated Coagulation and Fibrinolysis Using a Filtration Technique and Western Blotting

Pål Andrè Holme

¹The Research Institute for Internal Medicine, University of Oslo, Norway

,

Nils Olav Solum

¹The Research Institute for Internal Medicine, University of Oslo, Norway

,

Frank Brosstad

¹The Research Institute for Internal Medicine, University of Oslo, Norway

,

Magnus Røger

²Institute of Pathology, Rikshospitalet, University of Oslo, Norway

,

Michael Abdelnoor

³Clinical Research Unit, Ullevål Hospital, University of Oslo, Norway

› Author Affiliations

Abstract

PDF Download

Summary

Platelet vesiculation in vitro is correlated to platelet activation. It was therefore considered of interest to see if microvesicles (MV) are present in blood in clinical situations associated with platelet activation in vivo. Patients with both activated coagulation and fibrinolysis, implying that thrombin has been generated, suit such a purpose. Thus, the aim of this study was to investigate whether microvesicles could be detected in patients with activated coagulation and fibrinolysis, as diagnosed by the presence of soluble fibrin (positive ethanol gelation tests) and positive tests for fibrin degradation products (FDP). Platelet-rich plasma was prepared from citrated blood from patients (n = 22) and healthy controls (n = 32) matched as to age and sex. The intact platelets were removed from plasma by centrifugation. Any MV present were isolated from the platelet-free plasma by a filtration procedure, washed, solubilized in Triton X-100 and subjected to SDS-PAGE with Western blotting using a MAb against GPIIba as an indicator of the presence of microvesicles. All of the 22 patients showed the presence of microvesicles detectable by the content of GPIIba, whereas this could be observed in only 4 out of the 32 normal controls and then in small or trace amounts only. The presence of microvesicles among cell-derived material in the plasma of two of the patients was also confirmed by electron microscopy. To the best of our knowledge this is the first report on the presence of microvesicles in plasma from patients with both activated coagulation and fibrinolysis. Thus, the isolation of the microvesicles by the filtration technique allowed studies of the chemical composition of the microvesicles, and demonstrated the presence of microvesicles in situations where platelets are expected to have been activated in vivo and a tendency to thrombosis exists.

PDF (588 kb)

References

References
1 Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor \h and express prothrombinase activity. J Biol Chem 1988; 263: 18205-18212
2 Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-17057
3 Wiedmer T, Shattil S, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor \h receptor. Biochemistry 1990; 29: 623-632
4 Holme PA, Brosstad F, Solum NO. The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation. Thromb Haemost 1993; 70: 681-686
5 Sandberg H, Bode AP, Dombrose FA, Lentz BR. Expression of coagulant activity in human platelets. Release of membranous vesicles providing platelet factor 1 and platelet factor 3. Thromb Res 1985; 39: 69-79
6 Bode AP, Sandberg H, Dombrose FA, Lentz BR. Association of factor y activity with membranous vesicles released from human platelets: requirement for platelet stimulation. Thromb Res 1985; 39: 49-61
7 George JN, Pickett EB, Sauceman S. et al Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340-348
8 Jy W, Horstman L, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992; 119: 334-345
9 Khan I, Zucker-Franklin D, Karpatkin S. Microthrombocytosis and platelet fragmentation associated with idiopathic/autoimmune thrombocytopenic purpura. Br J Haematol 1975; 31: 449-460
10 Abrahams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelet and platelet-derived microparticles. Blood 1990; 75: 128-138
11 Soria J, Soria C, Boucheix C, Mirshahi M, Perrot JY, Bemardou A, Samama M, Rosenfeld C. Monoclonal antibodies that react preferentially with fibrinogen degradation products or with cross-linked fibrin split products. Ann NY Acad Sci 1983; 408: 665-666
12 Godal HC, Abildgaard U, Kierulf P. Ethanol gelation and fibrin monomers in plasma. Scand J Haematol 1971; 13: 189-191
13 Laemmli UK. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature 1970; 227: 680-682
14 Le Stourgeon WM, Beyer AL. The rapid isolation, high resolution electrophoretic characterisation and purification of nuclear proteins. Methods Cell Biol 1977; 16: 387-406
15 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354
16 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye binding. Anal Bio-chem 1976; 72: 248-254
17 Takayama M, Itoh S, Nagasaki T, Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chem Acta 1977; 79: 93-98
18 Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall 1992
19 Hennekens CH, Buring JE. Epidemiology in medicine. Boston, Toronto: Little, Brown and company 1987
20 Hasty DL, Hay ED. Freeze-fracture studies of the developing cell surface. II. Particle-free membrane blisters on glutaraldehyde-fixed corneal fibroblasts are artefacts. J Cell Biol 1978; 78: 756-768
21 Schook P. The effective osmotic pressure of the fixative for transmission and scanning electron microscopy. Acta Morphol Neerl Scand 1980; 18: 31-45
22 Røger M, Huitfeldt H, Hovig T. Ultrastructural morphometric analysis of human blood platelets exposed to minimal handling procedures. APMIS 1992; 100: 922-929